ClinicalTrials.Veeva

Menu

Diastolic Function in Myotonic Dystrophy Type 1

C

Centre d'Investigation Clinique et Technologique 805

Status

Enrolling

Conditions

Diastolic Dysfunction

Study type

Observational

Funder types

Other

Identifiers

NCT06029192
ECHO-DM1

Details and patient eligibility

About

Myotonic dystrophy type 1 (DM1) is a neuromuscular disorder in relation with an unstable expansion of CTG repeat. Patients with DM1 are at risk of arrhythmia and conduction disorders. Mortality are mainly related to respiratory failure and sudden death. Patients with DM1 may suffer from obesity, arterial hypertension, diabetes mellitus and sleep apnea. These comorbidities are classically associated with left ventricular diastolic dysfunction (DD) .

The investigators aim to assess the prevalence of left ventricular diastolic dysfunction in patients with myotonic dystrophy type 1 , the distribution of DD grading as well as the long-term prognosis of DM1 patients with a left ventricular diastolic dysfunction.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with genetic proven myotonic dystrophy type 1
  • who experienced a Doppler- Echocardiography including an assessment of the left ventricular diastolic function

Exclusion criteria

  • wall motion basal abnormalities
  • significant valvular disease

Trial contacts and locations

1

Loading...

Central trial contact

Abdallah FAYSSOIL, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems